Recent advances for cancer detection and treatment by microfluidic
Numerous cancer-associated deaths are owing to a lack of effective diagnostic and therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a precise, quick, and user-friendly technique for cancer diagnosis and treatment. Microfluidic devices can detect many cancer-diagnostic factors from biological fluids and also generate appropriate nanoparticles for drug delivery. Thus, microfluidics may be valuable in the cancer field due to its high sensitivity, high throughput, and low cost. In the present article, we aim to review recent achievements in the application of microfluidic systems for the diagnosis and treatment of various cancers. Although microfluidic platforms are not yet used in the clinic, they are expected to become the main technology for cancer diagnosis and treatment. Microfluidic systems are proving to be more sensitive and accurate for the detection of cancer biomarkers and therapeutic strategies than common assays. Microfluidic lab-on-a-chip platforms have shown remarkable potential in the designing of novel procedures for cancer detection, therapy, and disease follow-up as well as the development of new drug delivery systems for cancer treatment.
Microfluidic point-of-care diagnostic devices for global health - Concordia University
Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer - ScienceDirect
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Liquid Biopsy Test: Protocol and Steps
Research - Linnes Lab - Purdue University
Emerging integrated SERS-microfluidic devices for analysis of cancer-derived small extracellular vesicles - Lab on a Chip (RSC Publishing) DOI:10.1039/D3LC00156C
Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer - ScienceDirect
Biofilm testing under flow - Elveflow
Ciprian Iliescu on LinkedIn: Our review paper Recent advances in microfluidic methods in cancer liquid…
Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment